Survival results of a randomised two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of S-1 plus cisplatin (SC) and paclitaxel plus cisplatin (PC) followed by D2 gastrectomy for resectable advanced gastric cancer-Reference-Cited by-同舟云学术

Survival results of a randomised two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of S-1 plus cisplatin (SC) and paclitaxel plus cisplatin (PC) followed by D2 gastrectomy for resectable advanced gastric cancer

Published:2016-07 Issue: Volume:62 Page:103-111
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Yoshikawa Takaki,Morita Satoshi,Tanabe Kazuaki,Nishikawa Kazuhiro,Ito Yuichi,Matsui Takanori,Fujitani Kazumasa,Kimura Yutaka,Fujita Junya,Aoyama Toru,Hayashi Tsutomu,Cho Haruhiko,Tsuburaya Akira,Miyashita Yumi,Sakamoto Junichi

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference28 articles.

1. Estimated cancer incidence, mortality and prevalence worldwide in 2012;GLOBOCAN2012,2012

2. Gastrointestinal cancer: adjuvant chemotherapy after D2 gastrectomy for gastric cancer;Yoshikawa;Nat Rev Clin Oncol,2012

3. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine;Sakuramoto;N Engl J Med,2007

4. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial;Bang;Lancet,2012

5. Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer;Sasako;J Clin Oncol,2011

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ten-Year Follow-Up After Chemotherapy and Conversion Surgery for Human Epidermal Growth Factor Receptor 2-Positive Stage IV Esophagogastric Junction Cancer With a Pathological Complete Response: A Case Report;Cureus;2024-05-13

2. Ten-year follow-up after chemotherapy (S1 + cisplatin + trastuzumab) and surgery for human epidermal growth factor receptor 2-positive stage IV esophagogastric junction cancer with pathological complete response: a case report;2023-11-21

3. Perioperative Chemotherapy versus Adjuvant Chemotherapy in Patients with Resectable Gastric Cancer: A Systematic Review with meta-analysis;Critical Reviews in Oncology/Hematology;2023-08

4. Long-term survival outcome of locally advanced gastric cancer patients who achieved a pathological complete response to neoadjuvant chemotherapy;International Journal of Clinical Oncology;2023-06-15

5. Combined with prognostic nutritional index and IgM for predicting the clinical outcomes of gastric cancer patients who received surgery;Frontiers in Oncology;2023-06-09